Spectrum Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Spectrum Pharmaceuticals

13/08/2021 03:38

* Spectrum Pharmaceuticals Inc  SPPI.OQ  reported a quarterly
adjusted loss of 32 cents​​ per share for the quarter ended in
June. The mean expectation of five analysts for the quarter was
for a loss of 25 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Spectrum Pharmaceuticals Inc's reported EPS for the quarter
was a loss of 32 cents​.
* The mean earnings estimate of analysts had risen by
about 15.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Spectrum Pharmaceuticals Inc shares had fallen by 37.3% this
quarter and lost 31.1% so far this year.
* The company reported a quarterly loss of $50.13 million.
* Wall Street's median 12-month price target for Spectrum
Pharmaceuticals Inc is $8.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 13 at 02:37 a.m.  ​All
figures in US dollars unless otherwise stated